Akynzeo (netupitant/palonosetron) capsules — CareFirst (Caremark)
Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy
Initial criteria
- Authorization may be granted when the requested drug is prescribed for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy
Approval duration
6 months